about
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help c...
Read More
5.41
-0.09
(-1.64%)
6.3M
XNAS Volume
XNAS 02 Apr, 2026 5:30 PM (EDT)
Low Financial Strength
Mid Valuation
Technically Bearish
Weak Stock
These stocks have weak financials and momentum. Buying interest is low. While the stock is affordable, investors should exercise caution
View Similar
Embed DVM
Certara Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..